{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-072022","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2023-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.915344+00:00","generated_at":"2026-06-18T00:56:14.224343+00:00","sec_items":["1.01","2.03","3.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SeaStar Medical closes initial $3.3M tranche of $9.8M convertible note private placement","bullets":["Initial note: $3.26M face, 8% OID, 7% interest, matures June 15, 2024; net proceeds $2.37M.","Conversion price $2.70/share; warrant to buy 328,352 shares at $2.97, five-year term.","Up to $9.8M total via three additional closings, contingent on registration and shareholder approval.","Extended maturity of existing promissory notes from Maxim Group and LM Funding to June 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-072022","json":"https://secwatch.observer/filing/0001193125-23-072022.json","markdown":"https://secwatch.observer/filing/0001193125-23-072022.md","text":"https://secwatch.observer/filing/0001193125-23-072022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000119312523072022/0001193125-23-072022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000119312523072022/d463790d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T00:56:14.224343+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"35006fe35f9b2e607074e959e35f72c2a0a19672","claim":"SeaStar Medical Holding Corp incurred convertible notes of $3,260,869.57 with an institutional investor at 7% maturing June 15, 2024.","evidence_excerpt":"the Company issued a Note, convertible into 1,207,729 shares of Common Stock at an initial conversion price of $2.70, in a principal amount of $3,260,869.57","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000119312523072022/0001193125-23-072022-index.htm","confidence":1.0,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$3,260,869.57"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Rate","value":"7%"},{"label":"Maturity","value":"June 15, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"4dfb372e08fe3f5e1aa11ccf02d61731add6ba44","claim":"SeaStar Medical Holding Corp entered into Securities Purchase Agreement with an institutional investor valued at up to approximately $9.8 million (effective 2023-03-15).","evidence_excerpt":"On March 15, 2023, SeaStar Medical Holding Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Purchaser”), pursuant to which the Company agreed to sell and issue to the Purchaser, in a series of up to four closings, senior unsecured convertible notes (the “Notes”), convertible into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), in a principal amount of up to approximately $9.8 million and warrants (the “Warrants”) to purchase shares of the Company’s Common Stock.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000119312523072022/0001193125-23-072022-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Value","value":"up to approximately $9.8 million"},{"label":"Effective","value":"2023-03-15"}],"fact_type":"material_agreement"},{"claim_id":"5277d949e002dfac9441d7ae2db9c10047ba3221","claim":"SeaStar Medical Holding Corp entered into Registration Rights Agreement with the Purchaser (effective 2023-03-15).","evidence_excerpt":"On March 15, 2023, in connection with the sale and issuance of the Notes and Warrants, the Company entered into a Registration Rights Agreements (the “Registration Rights Agreement”) with the Purchaser.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000119312523072022/0001193125-23-072022-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"the Purchaser"},{"label":"Effective","value":"2023-03-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}